Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inboxGmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscriptionClick this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Exclusive Story from MarketBeat
Up Over 200% in 2026, What's Next for AI Stock Aehr Test Systems?Written by Leo Miller. Date Posted: 4/10/2026. 
Key Points
- AEHR has skyrocketed in 2026, being among the market's top performers.
- The company is generating orders and interest from many corners of the AI infrastructure market, exciting investors.
- The company's momentum in winning deals points to good things ahead, but AEHR's valuation remains a key risk.
- Special Report: Have $500? Invest in Elon’s AI Masterplan
Aehr Test Systems (NASDAQ: AEHR), a small company in the semiconductor industry, has been indisputably one of the market’s best performers of 2026. During the year, AEHR is one of just five stocks in the Russell 3000 Index to deliver a return of more than 200%. Understanding the scope of the Russell 3000 helps put this into perspective. The index measures the performance of the 3,000 largest U.S. stocks, representing around 98% of the investable U.S. equity market. Because of this, many consider the Russell 3000 to be the most comprehensive gauge of the U.S. stock market. This shows just how big a standout AEHR has been in 2026. The company, which makes equipment to stress test the performance of semiconductors, has announced multiple deals throughout the year. And, despite posting mixed results in its latest earnings report, the stock surged by nearly 26% afterward. Let’s dive into what’s driving Aehr’s explosive gains and what investors should consider going forward. Silicon Photonics Deal Boosts AEHR StockNotably, most of Aehr’s 2026 gain has come over less than two weeks. The stock started 2026 near $20, and, near the end of March, settled near $30. After that, shares more than doubled in value, eclipsing the $65 mark. March 31 proved to be a significant catalyst, with shares shooting up more than 23%. That day, the company announced another key customer win. The company said it has gained a new silicon photonics customer, which was ordering multiple of its FOX-XP systems. Aehr notes that this customer is “a global leader in networking products and solutions and a major supplier to the data center optical transceiver market.” This is particularly interesting, as optical transceivers are critical components being rapidly adopted in artificial intelligence (AI) data centers. As data centers look to process increasingly large amounts of information, optical transceivers are a critical technology that makes this possible. Companies like Coherent (NYSE: COHR) and Lumentum (NASDAQ: LITE), which make optical transceivers, have seen their share prices soar over the recent past. For Aehr, the ability to get in on this growing market is a key win. Importantly, Aehr notes that follow-on orders are possible in 2026. Furthermore, this customer is purchasing these systems for both engineering qualification and high-volume production. Typically, customers test (qualify) systems first before using them in large-scale production. However, this customer is doing both simultaneously. This signals confidence in Aehr’s technology and that the customer’s needs are urgent, adding weight to the idea that more orders could follow. Aehr Looks Poised to See Significant Growth in Fiscal 2027In its latest quarter, Aehr posted revenue of $10.3 million, falling below estimates of $10.85 million. On the other hand, the company's loss during the quarter of 5 cents was smaller than the 7 cents analysts expected. The company reiterated its guidance of $25 million to $30 million in revenue during the second half of its fiscal year 2026 (FY2026). Aehr also maintained its guidance for an adjusted loss per share of between 9 cents and 5 cents. Note that Aehr just reported its Q3 FY2026 results, as its fiscal reporting period is multiple quarters ahead of the calendar year period. However, the more compelling story for this company requires looking further out. Notably, during the quarter, Aehr recorded bookings of $37.2 million, over 3.5 times higher than its revenue. This strongly points to larger revenues ahead. The company now sees its second half FY2026 bookings coming in at the high end of its $60 million to $80 million range. The company’s effective backlog also hit a record of $50.9 million, slightly above the high end of its FY2026 revenue guidance. This provides a significant layer of support for sales to move higher in FY2027. AEHR Continues to Show It Is Not a Name to IgnoreOverall, Aehr keeps proving that it can win customers and orders. It has relationships in place with an AI-processor developer and silicon photonics developers, two technologies seeing strong and growing demand. It is also in discussions with another AI processor supplier, multiple high-bandwidth memory companies, and a NAND flash supplier. These memory technologies are experiencing some of the fastest growth in the AI infrastructure market. It's difficult to call the stock undervalued, as AEHR has a market capitalization above $2 billion, yet expects to generate up to just $50 million in sales during FY2026. However, the company does have strong growth potential ahead in the rapidly expanding AI market. With shares up so significantly, downside risk is palpable. However, given Aehr’s demonstrated success, it would not be overly surprising for the company to see future wins that drive shares higher. Notably, analysts at Craig Hallum upgraded AEHR from a Hold to a Buy after the company’s latest earnings report. The firm set a $68 price target on the stock, a level which shares exceeded soon after. |
Post a Comment
0Comments